GDF15 was previously shown to mediate adult body weight loss in cachexia and obesity settings (Johnen et al, 2007; Tsai et al, 2013), through its action in the hypothalamus (reducing Npy and increasing Pomc expression) that regulates food intake. Here, NPY is linked to obesity disorder.